REVISTA
BRASILEIRA
DE
ANESTESIOLOGIA
PublicaçãoOficialdaSociedadeBrasileiradeAnestesiologiawww.sba.com.br
REVIEW
ARTICLE
Effect
of
dexmedetomidine
in
children
undergoing
general
anesthesia
with
sevoflurane:
a
meta-analysis
Marco
Aurélio
Soares
Amorim
a,∗,
Catia
Sousa
Govêia
b,c,d,
Edno
Magalhães
c,e,f,
Luís
Cláudio
Araújo
Ladeira
g,
Larissa
Govêia
Moreira
h,
Denismar
Borges
de
Miranda
i,jaCentrodeEnsinoeTreinamentoJoséQuinan,Goiânia,GO,Brazil
bUniversidadedeBrasília(UnB),CentrodeEnsinoeTreinamento,Brasília,DF,Brazil cSociedadeBrasileiradeAnestesiologia,RiodeJaneiro,RJ,Brazil
dUniversidadedeBrasília(UnB),FaculdadedeCiênciasMédicas,Brasília,DF,Brazil eUniversidadedeBrasília(UnB),Brasília,DF,Brazil
fUniversidadeFederaldeSãoPaulo(Unifesp),SãoPaulo,SP,Brazil gHospitalUniversitáriodeBrasília,Brasília,DF,Brazil
hSecretariadeSaúdedoDistritoFederal,Brasília,DF,Brazil
iPontifíciaUniversidadeCatólicadeGoiás(PUC-GO),Goiânia,GO,Brazil
jUniversidadeFederaldeGoiás(UFG),InstitutodeMedicinaTropicaleSaúdePública,Goiânia,GO,Brazil
Received18December2015;accepted15February2016 Availableonline25November2016
KEYWORDS
Generalanesthesia; Inhalational anesthetics; Dexmedetomidine; Psychomotor agitation; Meta-analysis
Abstract
Backgroundandobjectives: Sevofluraneisoftenusedinpediatricanesthesiaandisassociated
withhighincidenceofpsychomotoragitation.Insuchcases,dexmedetomidine(DEX)hasbeen used,but itsbenefit andimplicationsremainuncertain.We assessedthe effectsofDEXon agitationinchildrenundergoinggeneralanesthesiawithsevoflurane.
Method: Meta-analysis ofrandomizedclinicalanddouble-blindstudies,withchildren
under-going electiveproceduresundergeneralanesthesiawithsevoflurane,usingDEXorplacebo. WesoughtarticlesinEnglishinPubMeddatabaseusingthefollowingterms:Dexmedetomidine, sevoflurane(MethylEthers/sevoflurante),andagitation(PsychomotorAgitation).Duplicate arti-cleswithchildrenwhoreceivedpremedicationandusedactivecontrolwereexcluded.Itwas adoptedrandomeffectsmodelwithDerSimonian---Lairdtestingandoddsratio(OR)calculation for dichotomousvariables,andstandardizedmeandifferencefor continuous variables,with theirrespective95%confidenceinterval(CI).
Results:Of 146studiesidentified,10wereselected totaling558patients(282inDEXgroup
and276controls).TheuseofDEXwasconsideredaprotectivefactorforpsychomotoragitation (OR=0.17;95%CI0.13---0.23;p<0.0001)andnauseaandvomitinginPACU(OR=0.49;95%CI 0.35---0.68;p<0.0001).Wake-uptimeandPACUdischargetimewerehigherinthe dexmedeto-midinegroup.Therewasnodifferencebetweengroupsfor extubationtimeanddurationof anesthesia.
∗Correspondingauthor.
E-mail:[email protected](M.A.Amorim).
http://dx.doi.org/10.1016/j.bjane.2016.02.007
Conclusion:Dexmedetomidinereducespsychomotoragitationduringwake-uptimeofchildren undergoinggeneralanesthesiawithsevoflurane.
©2016SociedadeBrasileiradeAnestesiologia.PublishedbyElsevierEditoraLtda.Thisisan openaccessarticleundertheCCBY-NC-NDlicense( http://creativecommons.org/licenses/by-nc-nd/4.0/).
PALAVRAS-CHAVE
Anestesiageral; Anestésicos inalatórios; Dexmedetomidina; Agitac¸ão
psicomotora; Metanálise
Efeitodadexmedetomidinaemcrianc¸assubmetidasàanestesiageral comsevoflurano:umametanálise
Resumo
Justificativaeobjetivos: Sevofluranoéfrequentementeusadoemanestesiapediátricaeestá
associadoàaltaincidênciadeagitac¸ãopsicomotoraaodespertar.Nessescasosa dexmedeto-midina(dex)temsidousada,porémpermanecemincertosseusbenefíciosesuasimplicac¸ões. Foramavaliados osefeitos dadex sobre aagitac¸ão nodespertar decrianc¸as submetidasà anestesiageralcomsevoflurano.
Método: Metanálisedeensaiosclínicosrandomizadoseduplamenteencobertos,comcrianc¸as
submetidas aprocedimentos eletivos sob anestesiageral comsevoflurano,que usaram dex
ou placebo. Buscaram-se artigos em língua inglesa nabase de dados Pubmed com termos
como Dexmedetomidine, sevoflurane (MethylEthers/sevoflurane) eagitation(Psychomotor
Agitation).Artigosduplicados,comcrianc¸asquereceberammedicac¸ãopré-anestésicaeque
usaramcontroleativoforamexcluídos.Adotou-semodelodeefeitosaleatórioscomtestesde DerSimonian-Lairdecálculodeoddsratio(OR)paravariáveisdicotômicasediferenc¸ademédia padronizadaparavariáveiscontínuas,comseusrespectivosintervalosdeconfianc¸ade95%(IC).
Resultados: Dos146estudosidentificados,10foramselecionados,com558pacientes(282no
grupodexe276controles).Ousodadexfoiconsideradofatordeprotec¸ãoparaagitac¸ão psi-comotora(OR=0,17;95%IC0,13-0,23;p<0,0001)eparanáuseasevômitosnaSRPA(OR=0,49; 95%IC0,35-0,68;p<0,0001).TempoparadespertareparaaltadaSRPAforammaioresnogrupo dexmedetomidina.Nãohouvediferenc¸aentreosgruposparatempodeextubac¸ãoedurac¸ão daanestesia.
Conclusão:A dexmedetomidinareduzaagitac¸ãopsicomotoranodespertardecrianc¸as
sub-metidasàanestesiageralcomsevoflurano.
©2016SociedadeBrasileiradeAnestesiologia.PublicadoporElsevierEditoraLtda.Este ´eum artigoOpen Accesssobumalicenc¸aCCBY-NC-ND( http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Sevoflurane is widely used in pediatric anesthesia for its pharmacological profile, which allows rapid inhalational inductionand awakeningfromanesthesia, low hepatotox-icityandhemodynamicstability.1However,theoccurrence
ofagitationisacommonphenomenoninchildrenundergoing generalanesthesiawithsevoflurane.1
Emergence agitation in children wasfirst described in the early 1960s and is characterized by a dissociated state of consciousness in which the child becomes incon-solable,irritable,uncooperative,andsometimesaggressive. Althoughtemporary,itisanextremelydistressingeventfor children,parents,andhealthprofessionals.2
Prevalence of agitation varies from 25% to 80% in the literature, depending on the definition and criteria used by the authors.1,3 It is influenced by the technique
and anesthetic agents.4 Different drugs such as opioids,
ketamine, benzodiazepines, and ␣2-agonists,2 have been
used in the prevention and treatment of agitation, but withvaryingsuccess,whichcontributestothedevelopment
of studies to improve perioperative care delivered to children.
Dexmedetomidine (Dex), dextrorotatoryenantiomer of medetomidine,isahighlyselective␣2-adrenergic,withan ␣2:␣1receptorratioof1,600:1,andimportantsedativeand
analgesiceffects.5Itssedativeeffectoccursthrough
inter-actionwithpostsynaptic␣2-receptorsinthelocuscoeruleus,
reducesnoradrenalinrelease,andfacilitatestheaction of inhibitory neurons, particularly gamma-aminobutyric acid system.Theanalgesiceffectispromotedbytheactionof␣2
-receptorsondorsalhornandsupraspinalcordanddecreased releaseofsubstanceP.6
Methods
This is a meta-analysis of clinical trials evaluating the use of dexmedetomidine to prevent emergence agi-tation in children undergoing general anesthesia with sevoflurane. PRISMA guidelines7 were followed to
per-form a systematic review and meta-analysis of random-ized controlled trials. Articles in English (2000---2014) were selected in the Pubmed database with key-words such as Dexmedetomidine, sevoflurane (Methyl Ethers/sevoflurante)andagitation(PsychomotorAgitation), or its synonyms separated by AND/OR interlocutors with the following search strategy: (dexmedetomidine[MeSH Terms]) OR adrenergic alpha agonists[MeSH Terms]) OR dexmedetomidine[Title/Abstract]) OR dexmedetomi-dine) OR adrenergic alpha agonists) AND anesthet-ics, intravenous[MeSH Terms]) OR anesthetics, intra-venous[Title/Abstract])AND(hypnoticsandsedatives[MeSH Terms])) OR (hypnotics and sedatives[Title/Abstract])) AND sevoflurane) OR sevoflurane[Title/Abstract]) OR sevoflurane[Supplementary Concept]))ANDchildren[MeSH Terms]))ANDagitation,psychomotor[MeSHTerms].In addi-tiontothesearch,wereviewedmanuallythereferencesof studiesmeeting theinclusioncriteria, inordertoidentify originalstudiesthatwerenotpreviouslyfound.
Randomized, double-blind, controlled studies, with children (under 10 years old) undergoing elective proce-dures under general anesthesia with sevoflurane, using dexmedetomidineorplacebowereincluded.Duplicate arti-cles or with children using premedication, involving only sedationandusingactivecontrolwereexcluded.
Two independent researchers (MA and CG) conducted a preliminary assessment of the titles/abstracts and data extraction. Selectedstudies were read in full considering the inclusion and exclusion criteria. In case of disagree-ment, a third researcher (LC) made the final evaluation. Dataregarding patient’s age, anesthesia(Dex dose), type ofprocedure,andoutcomeswererecordedona standard-ized form developed by the authors. For this study, the followingoutcomeswereconsidered:emergence agitation (definedby each paper according tothe scale used: Pae-diatricAnaesthesiaEmergenceDelirium---PAED,8Watcha,9
andfive-pointscale)10;PONV(presentorabsent);andtimes
forextubation,emergence,PACUdischarge,anddurationof anesthesia(timeintervaldescribedbyarticlesinminutes). Sensitivity analysis was planned to explore sources of heterogeneity between studies, when present. Statistical heterogeneitywascalculatedusingthechi-squaremethod (2) and Higgins’ test (I2).11 Presence of heterogeneity
was considered at p<0.05 and I2≥50%. Odds ratio (OR) with 95% confidence interval (CI) was used to quantify thestatistical differencebetweengroups fordichotomous variablesandstandardizedmeandifference(SMD)for con-tinuous variables (time in minutes). After assessing the qualityandstatisticalheterogeneityofstudies,weadopted the random effects model using the DerSimonian---Laird12
method and statistical analysis using the BioEstat® 5.0 software.13Theassessmentofpotentialforpublicationbias
was made by visual analysis of funnel plots and Begg’s14
and Egger’s15 tests, with statistical significance level set
at5%.
Results
Initially,146studieswereidentified(116studiesinPubmed and30 manuallysearched),of which10 wereselected to composethismeta-analysis,asshowninFig.1.
The 10studies included 558patients, 282in the inter-vention group, and 276 in the control group (Table 1). ThreestudieswereconductedinTurkey,17---19 threestudies
inChina,21---23 andothersstudiesinChile,1UnitedStates,16
Japan,20andSouthKorea.24
Emergenceagitationwasassessedin10studies,andthe useofdexmedetomidine wasconsideredaprotection fac-tor(OR=0.17;95% CI0.13---0.23; p<0.0001), as shown in
Fig.2.Surgerysubgroupanalysisshowednoeffectchange (urogenital1,24 with OR=0.14; 95% 0.04---0.44; p=0.0008;
ophthalmic21,23withOR=0.06;95%CI0.01---0.45;p=0.0067,
ENT,17,19withOR=0.20;95%CI0.14---0.30;p<0.0001).
The use of dexmedetomidine reduces the incidence of PONV (Fig. 3), with OR=0.49 (95% CI 0.35---0.68 and
p<0.0001).
Emergencetimewasassessedinsevenstudies,17---19,21---23
(SMD=1.78; 95% CI 1.12---2.44; p=0.0001) and PACU dis-chargeinfourstudies1,16,18,23(SMD=8.54;95%CI6.62---10.44;
p<0.0001),higherindexmedetomidinegroup.
Therewasnodifferencebetweengroupsregarding extu-bation time (SMD=0.70; 95% CI 0.33---1.06; p=0.0002), assessedin eight studies,1,16---19,21---23 and duration of
anes-thesia(SMD=3.19;95%CI−0.79---7.14;p=0.11),assessedin
sevenstudies.1,16,18---20,23,24
Based on the funnel plot analysis (Fig. 4), thereis an asymmetry with no small sample studies to the right of thesummaryeffect,whichsupportsapotentialfor publica-tionbiasconfirmedbyBegg’s(p=0.02)andEgger’s(p=0.03) tests.
Discussion
Thismeta-analysisconsistsof10randomizedcontrolled tri-alspublishedbetween 2004 and2014,which assessedthe effectofdexmedetomidineonemergenceagitationin chil-drenundergoinggeneralanesthesiawithsevoflurane.
Search result (n=146)
Excluded duplicates (n=20)
Title and abstract reading (n=126)
Excluded: not relevant (n=104), adults (n=6) and
active control (n=1)
Eligible for full-text reading (n=15)
Studies included in the meta-analysis (n=10)
Excluded for using premedication (n=5)
Table1 Descriptionofselectedstudies.
Study Yearofpublication Studydetails n Age Proceduretype
Ibacache1 2004 Dex0.3mcgkg−1 30 1---10 Inguinalherniarepair,orchidopexy
andcircumcision Salinesolution 30
Shukry16 2005 Dex0.2mcgkg−1 23 1---10 Electivesurgeries
Salinesolution 23
Guler17 2005 Dex0.5mcgkg−1 30 3---7 Adenotonsillectomy
Salinesolution 30
Isik18 2006 Dex1mcgkg−1 21 1---10 Magneticresonanceimaging
Salinesolution 21
Erdil19 2009 Dex0.5mcgkg−1 30 2---7 Adenoidectomywithorwithout
myringotomy Salinesolution 30
Sato20 2010 Dex0.3mcgkg−1 39 1---9 Outpatientsurgery
Salinesolution 42
Lili21 2012 Dex0.5mcgkg−1 30 3---7 Vitrectomy
Salinesolution 30
He22 2013 Dex1mcgkg−1 32 3---7 Smallsuperficialsurgeries
Salinesolution 26
Chen23 2013 Dex1mcgkg−1 27 2---7 Strabismus
Salinesolution 24
Kim24 2014 Dex1mcgkg−1 20 1---5 Hernioplastyororchidopexy
Salinesolution 20
Weight (%) Control
(n/N)
9.39 11/30
11.21
12.27
4.82
12.32
19.39
9.54
0.22 (0.06-0.82)
0.24 (0.07-0.82)
0.17 (0.05-0.53)
0.08 (0.01-0.51)
0.24 (0.08-0.78)
0.16 (0.04-0.62)
7.40
8.87
4.75
100 14/23
17/30
10/21
14/30
27/42
13/30
11/26
11/24
11/20
0.01 0.1 0.2 0.5 1.0 2.0 5.0 10.0 139/276
Dex (n/N)
3/30
6/23
5/30
1/21
5/30
7/39
3/30
2/32
3/27
1/20
38/282
Favors dexmedetomidine
Favors control
Overall effect test: Z=11.92 (p<0.0001) Study
Ibacache 2004
Shukry 2005
Guler 2005
Isik 2006
Erdil 2009
Sato 2010
Lili 2012
He 2013
Chen 2013
Kim 2014
Total
Heterogeneity test;
χ2 = 3.19; df=9 (p=0.96); I2 = 0%
0.11 (0.02-0.49)
0.17 (0.04-0.66)
0.06 (0.01-0.41)
0.17 (0.13-0.23) 0.23 (0.09-0.57) OR (95% CI)
Figure 2 Meta-analysis of dexmedetomidine effect on emergence agitation in children undergoing general anesthesia with sevoflurane.
There was variation in dexmedetomidine dosage (0.2---1.0mcgkg−1),aswellasinadministrationtechnique. One used continuous infusion of dexmedetomidine16 and
the others used it for a short period, ranging from 5 to 10min. Regarding the time of administration, only one studyadministeredthedrugat theendoftheprocedure17
and all others after induction of anesthesia, with similar resultsregardingemergenceagitation,whichconfirmsthat thereisnoidealtimefordexmedetomidineadministration. The causes of emergence agitation following general anesthesiaaremultifactorial;itmayinvolvepain,anxiety, anddisorientationonrapid awakening.25 Inanattempt to
minimizethisevent,numerousdrugshavebeenused,such as opioids, ketamine, benzodiazepines, and ␣2-agonists,
but with uncertain results.2 This meta-analysis presents
dexmedetomidine as a protective factor for emergence agitation in children undergoing general anesthesia with sevoflurane, similar result already described by other authors.2 Although the actual mechanism for this effect
remains unknown, it is believed that the analgesic and sedative effects of dexmedetomidine contribute to this phenomenon, aspostoperative analgesic consumptionwas lower.2
Sevoflurane has been associated with high incidence of emergence agitation in children undergoing general anesthesia,1,17 evenwithout surgery.18 Thisfact isnot yet
0.01 0.1 0.2 0.5 1.0 2.0 5.010.0
Favors dexmedetomidine
Favors control
Overall effect test: Z=4.21 (p<0.0001) Guler 2005
Isik 2006
Erdil 2009 1/30 1/30
Sato 2010 3/42 3/39
Chen 2013 4/27 11/24
Total 20/150 33/144 1/21 2/21 11/30 16/30
7.72 1.00 (0.10-10.18)
17.31 0.92 (0.20-4.35)
25.37 0.22 (0.06-0.81)
100 0.49 (0.35-0.68) 9.26
40.34 0.52 (0.19-1.43)
0.57 (0.07-4.74)
Heterogeneity test;
χ2=2.46; df=4 (p=0.65); I2=0%
Weight (%) Control
(n/N) Dex (n/N)
Study OR (95% CI)
Figure3 Meta-analysisofdexmedetomidineeffectonnauseaandvomitingincidenceinchildrenundergoinggeneralanesthesia withsevoflurane.
Standard error
Log odds ratio
1.120
–4.00 –2.00 0.00
0.280
Figure4 Funnelplotofdexmedetomidine effecton emer-genceagitationinchildrenundergoinggeneralanesthesiawith sevoflurane.
system.26Thedecreaseinemergenceagitationprovidedby
dexmedetomidine mayalsobejustifiedby thelower con-sumptionofsevoflurane.27
PONV are common complications in children undergo-ing general anesthesia with sevoflurane.18 Studies have
shown conflicting results on the effect of dexmedetomi-dine for this complication.20,23 In the present study, the
use of dexmedetomidine appeared as a protective fac-tor for the incidenceof nausea andvomiting. The use of dexmedetomidine hasbeen associated withreducedneed for postoperativeopioidanalgesics,whichimplies alower incidenceofnauseaandvomitinginducedbyopioid.28
More-over, dexmedetomidine hasbeen usedsuccessfully in the treatmentofcyclicalvomitingsyndromeinchildren,by yet-unknownmechanisms.29
Inthisstudy,thetimesofemergenceandPACUdischarge were considered statistically higher in dexmedetomidine group,justifiedbyitssedativeeffect,5butwithoutclinical
repercussions.17---19,22
Regardingthetimeofextubationanddurationof anes-thesia, thismeta-analysisfound nostatisticallysignificant differencebetweendexmedetomidine andcontrolgroups. Thisresultdisagreeswithsomeindividualstudies,by find-ingalongerextubationtimeanddurationofanesthesiain dexmedetomidinegroup.17,18
It is noteworthy that the studies used different scales to assess agitation. One study23 used the PAED scale8,
four studies1,16,21,24 used the Watcha scale,9 and five
studies17---20,22usedthefive-pointscale.10 Althoughonlythe
PAEDscalehasbeenvalidated,8theothersarewidelyused
inclinicalresearches.
Themeta-analysisqualitydependsontheselectionof rel-evantstudies, heterogeneity,anddetectionbias.2Despite
thedifferentstrategiesusedinthisstudytominimize possi-blebiases,itmaynotbediscarded.Asearchwasconducted inanimportantdatabaseandselectedworksweresubmitted to two independent evaluators. Double-blind randomized clinical trials were included. The use of random effects model is justified by the observation of clinical hetero-geneityidentifiedin studies:different dosesandtimes of dexmedetomidine administration, procedures, and emer-gence assessment scales. Another limitation of this study refersto the use of only one database for search, which confirmstheoccurrenceofpublicationbias,asidentifiedin thismeta-analysis.
Duetoitsgoodhemodynamicstability,dexmedetomidine hasbeen usedasanadjuvantanestheticandmaybeused aspre-anesthetic medication, during anesthesia, or even postoperatively,andprovidessedationandanalgesia5
with-outrespiratorydepression.17,18,20,30Itsuseentailsbenefits,
suchaslowerconsumptionofinhalationalanesthetics,21less
needfor postoperativeanalgesic andopioid drugs,2,28 and
loweroxygenconsumption.31
In conclusion, this meta-analysis highlights the use of dexmedetomidineinreducingemergenceagitationin chil-drenundergoinggeneralanesthesiawithsevoflurane.
Conflicts
of
interest
Theauthorsdeclarenoconflictsofinterest.
References
1.Ibacache ME, Mu˜noz HR, Brandes V, et al. Single-dose dexmedetomidinereducesagitationaftersevoflurane anesthe-siainchildren.AnesthAnalg.2004;98:60---3.
2.Pickard A, Davies P, Birnie K, et al. Systematic review and meta-analysis of the intraoperative ␣2-adrenergic ago-nists on postoperative behaviour in children. Br J Anaesth. 2014;112:982---90.
4.DahmaniS,StanyI,BrasherC,etal.Pharmacologicalprevention ofsevofluranoanddesfluranerelatedemergenceagitationin children:a meta-analysisofpublished studies.Br JAnaesth. 2010;104:216---23.
5.VillelaNR,NascimentoJuniorP.Usodedexmedetomidinaem anestesiologia.RevBrasAnestesiol.2003;53:97---113.
6.Gertler R, BrownHC, Mitchell DH,et al. Dexmedetomidine: anovelsedativeanalgesicagent. Proc(BaylUnivMedCent). 2001;14:13---21.
7.MoherD,LiberatiA,TetziaffJ,etal.Preferredreportingitems for systematicreviewsandmeta-analyses:thePRISMA state-ment.AnnInternMed.2009;151:264---9.
8.SikichN,LermanJ.Developmentandpsychometricevaluation ofthepediatricanesthesiaemergencedeliriumscale. Anesthe-siology.2004;100:1138---45.
9.Watcha MF, Ramirez-Ruiz M, White PF, et al. Periopera-tiveeffectsof oralketorolacand acetaminopheninchildren undergoing bilateral myringotomy. Can J Anaesth. 1992;39: 649---54.
10.ColeJW,MurrayDJ,McAlisterJD,etal.Emergencebehaviour inchildren:definingtheincidenceofexcitementandagitation followinganaesthesia.PaediatrAnaesth.2002;12:442---7. 11.HigginsJP,ThompsonSG.Quantifyingheterogeneityina
meta-analysis.StatMed.2002;15:1539---58.
12.DerSimonianR,LairdN.Meta-analysisinclinicaltrials.Control ClinTrials.1986;7:177---88.
13.Ayres M,AyresJunior M,Ayres DL,etal.BioEstat: aplicac¸ão estatísticanasáreasdasciênciasbiomédicas.4rded.Belém; 2007.
14.BeggCB,MazumdarM.Operatingcharacteristicsofarank corre-lationtestforpublicationbias.Biometrics.1994;50:1088---101. 15.Egger M, Davey Smith G, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629---34.
16.ShukryM,ClydeMC,KalarickalPL,etal.Doesdexmedetomidine preventemergencedeliriuminchildrenaftersevoflurane-based generalanesthesia?PaediatrAnaesth.2005;15:1098---104. 17.Guler G, Akin A, Tosun Z, et al. Single-dose
dexmedeto-midine reduces agitation and provides smooth extubation afterpediatricadenotonsillectomy.PaediatrAnaesth.2005;15: 762---6.
18.IsikB,ArslanM,DoganA, etal.Dexmedetomidinedecreases emergence agitation in pediatric patients after sevoflurane anesthesiawithoutsurgery.PaediatrAnaesth.2006;16:748---53.
19.Erdil F, Demirbilek S, Begec Z, et al. The effects of dexmedetomidine and fentanyl on emergence characteris-ticsafteradenoidectomyinchildren.AnaesthIntensiveCare. 2009;37:571---6.
20.SatoM,ShirakamiG,Tazuke-NishimuraM,etal.Effectof single-dosedexmedetomidine onemergenceagitationandrecovery profilesaftersevoflurane anesthesia in pediatric ambulatory surgery.JAnesth.2010;24:675---82.
21.Lili X, Jianjun S, Haiyan Z. The application of dexmedeto-midineinchildrenundergoingvitreoretinalsurgery.JAnesth. 2012;26:556---61.
22.He L, Wang X, Zheng S, et al. Effects ofdexmedetomidine infusiononlaryngeal maskairway removalandpostoperative recoveryinchildrenanaesthetised withsevoflurane.Anaesth IntensiveCare.2013;41:328---33.
23.Chen JY, Jia JE, Liu TJ, et al. Comparison of the effects of dexmedetomidine, ketamine, and placebo on emergence agitationafterstrabismussurgeryinchildren. CanJAnesth. 2013;60:385---92.
24.KimNY,KimSY,YoonHJ,etal.Effectoddexmedetomidineon sevofluranerequirementsandemergenceagitationinchildren undergoingambulatorysurgery.YonseiMedJ.2014;55:209---15. 25.VlajkovicGP,SindjelicRP.Emergencedeliriuminchildren:many
questions,fewanswers.AnesthAnalg.2007;104:84---91. 26.Woodforth IJ, Hicks RG, Crawford MR, et al.
Electroen-cephalographic evidence of seizure activity under deep sevofluraneanesthesiainanonepilepticpatient. Anesthesiol-ogy.1997;87:1579---82.
27.NaHS,SongIA,HwangJW,etal.Emergenceagitationinchildren undergoing adenotonsillectomy: a comparison ofsevoflurane vs.sevoflurane-remifentaniladministration.ActaAnaesthesiol Scand.2013;57:100---5.
28.LinTF,YehYC,LinFS,etal.Effectofcombining dexmedetomi-dineandmorphineforintravenouspatient-controlledanalgesia. BrJAnaesth.2009;102:117---22.
29.TobiasJD.Dexmedetomidineinthetreatmentofcyclicvomiting syndrome.PaediatrAnaesth.2005;15:709---10.
30.Mason KP, Lerman J. Dexmedetomidine in children: cur-rent knowledge and future applications. Anesth Analg. 2011;113:1129---42.